Top

Published in:

Open Access 01-06-2016 | Original Research

Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer

Authors: Jan S. Voorwinden, Jan P. C. Jaspers

Published in: Journal of Genetic Counseling | Issue 3/2016

Abstract

The psychological impact of an unfavorable genetic test result for counselees at risk for hereditary cancer seems to be limited: only 10–20 % of counselees have psychological problems after testing positive for a known familial mutation. The objective of this study was to find prognostic factors that can predict which counselees are most likely to develop psychological problems after presymptomatic genetic testing. Counselees with a 50 % risk of BRCA1/2 or Lynch syndrome completed questionnaires at three time-points: after receiving a written invitation for a genetic counseling intake (T1), 2–3 days after receiving their DNA test result (T2), and 4–6 weeks later (T3). The psychological impact of the genetic test result was examined shortly and 4–6 weeks after learning their test result. Subsequently, the influence of various potentially prognostic factors on psychological impact were examined in the whole group. Data from 165 counselees were analyzed. Counselees with an unfavorable outcome did not have more emotional distress, but showed significantly more cancer worries 4–6 weeks after learning their test result. Prognostic factors for cancer worries after genetic testing were pre-existing cancer worries, being single, a high risk perception of getting cancer, and an unfavorable test result. Emotional distress was best predicted by pre-existing cancer worries and pre-existing emotional distress. The psychological impact of an unfavorable genetic test result appears considerable if it is measured as “worries about cancer.” Genetic counselors should provide additional guidance to counselees with many cancer worries, emotional distress, a high risk perception or a weak social network.

Beran, T. M., Stanton, A. L., Kwan, L., Seldon, J., Bower, J. E., Vodermaier, A., & Ganz, P. A. (2008). The trajectory of psychological impact in BRCA1/2 genetic testing: does time heal? Annals of Behavioral Medicine, 36, 107–116. doi:10.1007/s12160-008-9060-9.CrossRefPubMed

Berkenstadt, M., Shiloh, S., Barkai, G., Bat-Mariam Katznelson, M., & Goldman, B. (1999). Perceived Personal Control (PPC): a new concept in measuring outcome of genetic counseling. American Journal of Medical Genetics, 82, 53–59. doi:10.1002/(SICI)1096-8628(19990101)82:1<53::AID-AJMG11>3.0.CO;2-#.CrossRefPubMed

Cella, D., Hughes, C., Peterman, A., Chang, C. H., Peshkin, B. N., Schwartz, M. D., Wenzel, L., et al. (2002). A brief assessment of concerns associated with genetic testing for cancer: the multidimensional impact of cancer risk assessment (MICRA) questionnaire. Health Psychology, 21, 564–572. doi:10.1037/0278-6133.21.6.564.CrossRefPubMed

Collins, V. R., Meiser, B., Ukoumunne, O. C., Gaff, C., St. John, D. J., & Halliday, J. L. (2007). The impact of predictive genetic testing for hereditary nonpolyposis colorectal cancer: three years after testing. Genetics in Medicine, 9, 290–297. doi:10.1097/GIM.0b013e31804b45db.CrossRefPubMed

Coyne, J. C., Benazon, N. R., Gaba, C. G., Calzone, K., & Weber, B. (2000). Distress and psychiatric morbidity among women from high-risk breast and ovarian cancer families. Journal of Consulting and Clinical Psychology, 68, 864–874. doi:10.1037/0022-006x.68.5.864.CrossRefPubMed

Den Heijer, M., Seynaeve, C., Vanheusden, K., Timman, R., Duivenvoorden, H. J., Tilanus-Linthorst, M., Menke-Pluijmers, M. B., et al. (2013). Long-term psychological distress in women at risk for hereditary breast cancer adhering to regular surveillance: a risk profile. Psycho-Oncology, 22, 598–604. doi:10.1002/pon.3039.CrossRef

Eijzenga, W., Bleiker, E. M., Hahn, D. E., Kluijt, I., Sidharta, G. N., Gundy, C., & Aaronson, N. K. (2014). Psychosocial aspects of hereditary cancer (PAHC) questionnaire: development and testing of a screening questionnaire for use in clinical cancer genetics. Psycho-Oncology. doi:10.1002/pon.3485.PubMed

Esplen, M. J., Madlensky, L., Butler, K., McKinnon, W., Bapat, B., Wong, J., Aronson, M., et al. (2001). Motivations and psychosocial impact of genetic testing for HNPCC. American Journal of Medical Genetics, 103, 9–15. doi:10.1002/ajmg.1493.CrossRefPubMed

Esplen, M. J., Cappelli, M., Wong, J., Bottorff, J. L., Hunter, J., Carroll, J., Dorval, M., et al. (2013). Development and validation of a brief screening instrument for psychosocial risk associated with genetic testing: a pan-Canadian cohort study. BMJ Open, 3, e002227. doi:10.1136/bmjopen-2012-002227.CrossRefPubMedPubMedCentral

Foster, C., Watson, M., Eeles, R., Eccles, D., Ashley, S., Davidson, R., Mackay, J., et al. (2007). Predictive genetic testing for BRCA1/2 in a UK clinical cohort: three year follow-up. British Journal of Cancer, 96, 718–724. doi:10.1038/sj.bjc.6603610.CrossRefPubMedPubMedCentral

Goldberg, D. P., & Williams, P. (1988). A User’s guide to the general health questionnaire. Windsor, UK: NFER Nelson.

Gopie, J. P., Vasen, H. F., & Tibben, A. (2012). Surveillance for hereditary cancer: does the benefit outweigh the psychological burden?—a systematic review. Critical Reviews in Oncology/Hematology, 83, 329–340. doi:10.1016/j.critrevonc.2012.01.004.CrossRefPubMed

Gritz, E. R., Peterson, S. K., Vernon, S. W., Marani, S. K., Baile, W. F., Watts, B. G., Amos, C. I., et al. (2005). Psychological impact of genetic testing for hereditary nonpolyposis colorectal cancer. Journal of Clinical Oncology, 23, 1902–1910. doi:10.1200/jco.2005.07.102.CrossRefPubMed

Halbert, C. H., Stopfer, J. E., McDonald, J., Weathers, B., Collier, A., Troxel, A. B., & Domchek, S. (2011). Long-term reactions to genetic testing for BRCA1 and BRCA2 mutations: does time heal women’s concerns? Journal of Clinical Oncology, 29, 4302–4306. doi:10.1200/JCO.2010.33.1561.CrossRefPubMedPubMedCentral

Hamilton, J. G., Lobel, M., & Moyer, A. (2009). Emotional distress following genetic testing for hereditary breast and ovarian cancer: a meta-analytic review. Health Psychology, 28, 510–518. doi:10.1037/a0014778.CrossRefPubMedPubMedCentral

Hanrahan, F., Field, A. P., Jones, F. W., & Davey, G. C. (2013). A meta-analysis of cognitive therapy for worry in generalized anxiety disorder. Clinical Psychology Review, 33, 120–132. doi:10.1016/j.cpr.2012.10.008.CrossRefPubMed

Helmes, A. W., Culver, J. O., & Bowen, D. J. (2006). Results of a randomized study of telephone versus in-person breast cancer risk counselling. Patient Education and Counseling, 64, 96–103. doi:10.1016/j.pec.2005.12.002.CrossRefPubMed

Hopwood, P., Keeling, F., Long, A., Pool, C., Evans, G., & Howell, A. (1998). Psychological support needs for women at high genetic risk of breast cancer: some preliminary indicators. Psycho-Oncology, 7, 402–412. doi:10.1002/(sici)1099-1611(1998090)7:5<402::aid-pon317>3.0.co;2-x.CrossRefPubMed

Lerman, C., Trock, B., Rimer, B., Jepson, C., Brody, D., & Boyce, A. (1991). Psychological side effects of breast cancer screening. Health Psychology, 10, 259–267. doi:10.1037/0278-6133.10.4.259.CrossRefPubMed

Lodder, L., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Duivenvoorden, H. J., Tibben, A., et al. (2001). Psychological impact of receiving a BRCA1/BRCA2 test result. American Journal of Medical Genetics, 98, 15–24. doi:10.1002/1096-8628(20010101)98:1<15::aid-ajmg1014>3.0.co;2-0.CrossRefPubMed

Meiser, B. (2005). Psychological impact of genetic testing for cancer susceptibility: an update of the literature. Psycho-Oncology, 14, 1060–1074. doi:10.1002/pon.933.CrossRefPubMed

Ockhuysen-Vermey, C. F., Henneman, L., van Asperen, C. J., Oosterwijk, J. C., Menko, F. H., & Timmermans, D. R. (2008). Design of the BRISC study: a multicentre controlled clinical trial to optimize the communication of breast cancer risk in genetic counselling. BMC Cancer, 8, 283–295. doi:10.1186/1471-2407-8-283.CrossRefPubMedPubMedCentral

Phelps, C., Bennett, P., Jones, H., Hood, K., Brain, K., & Murray, A. (2010). The development of a cancer genetic-specific measure of coping: the GRACE. Psycho-Oncology, 19, 847–854. doi:10.1002/pon.1629.CrossRefPubMed

Read, C. Y., Perry, D. J., & Duffy, M. E. (2005). Design and psychometric evaluation of the psychological adaptation to genetic information scale. Journal of Nursing Scholarship, 37, 203–208. doi:10.1111/j.1547-5069.2005.00036.x.CrossRefPubMed

Reichelt, J. G., Heimdal, K., Moller, P., & Dahl, A. A. (2004). BRCA1 testing with definitive results: a prospective study of psychological distress in a large clinical-based sample. Familial Cancer, 3, 21–28. doi:10.1023/b:fame.0000026820.32469.4a.CrossRefPubMed

Smets, E. M., Pieterse, A. H., Aalfs, C. M., Ausems, M. G., & van Dulmen, A. M. (2006). The Perceived Personal Control (PPC) questionnaire as an outcome of genetic counselling: reliability and validity of the instrument. American Journal of Medical Genetics, 140, 843–850. doi:10.1002/ajmg.a.31185.CrossRefPubMed

Smith, A. W., Dougall, A. L., Posluszny, D. M., Somers, T. J., Rubinstein, W. S., & Baum, A. (2008). Psychological distress and quality of life associated with genetic testing for breast cancer risk. Psycho-Oncology, 17, 767–773. doi:10.1002/pon.1291.CrossRefPubMed

Van Oostrom, I., Meijers-Heijboer, H. J., & Lodder, L. N. (2003). Long-term psychological impact of carrying a BRCA1/2 mutation and prophylactic surgery: a 5-year follow-up study. Journal of Clinical Oncology, 21, 3867–3874. doi:10.1200/jco.2003.10.100.CrossRefPubMed

Van Oostrom, I., Meijers-Heijboer, H. J., Duivenvoorden, H. J., Bröcker-Vriends, A. H., van Asperen, C. J., Sijmons, R. H., Seynaeve, C., et al. (2007). Prognostic factors for hereditary cancer distress six months after BRCA1/2 or HNPCC genetic susceptibility testing. European Journal of Cancer, 43, 71–77. doi:10.1016/j.ejca.2006.08.023.CrossRefPubMed

Voorwinden, J. S., Jaspers, J. P., ter Beest, J. G., Kievit, Y., Sijmons, R. H., & Oosterwijk, J. C. (2012). The introduction of a choice to learn pre-symptomatic DNA test results for BRCA or Lynch syndrome either face-to-face or by letter. Clinical Genetics, 81, 421–429. doi:10.1111/j.1399-0004.2011.01811.x.CrossRefPubMed

Title: Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer
Authors: Jan S. Voorwinden
Jan P. C. Jaspers
Publication date: 01-06-2016
Publisher: Springer US
Published in: Journal of Genetic Counseling / Issue 3/2016
Print ISSN: 1059-7700
Electronic ISSN: 1573-3599
DOI: https://doi.org/10.1007/s10897-015-9894-9

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Prognostic Factors for Distress After Genetic Testing for Hereditary Cancer

Abstract

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 3/2016

Predictive Genetic Testing and Alternatives to Face to Face Results Disclosure: A Retrospective Review of Patients Preference for Alternative Modes of BRCA 1 and 2 Results Disclosure in the Republic of Ireland

Survey of the Definition of Fetal Viability and the Availability, Indications, and Decision Making Processes for Post-Viability Termination of Pregnancy for Fetal Abnormalities and Health Conditions in Canada

Communication Between Breast Cancer Patients Who Received Inconclusive Genetic Test Results and Their Daughters and Sisters Years After Testing

Reproductive Decision-Making in MMR Mutation Carriers After Results Disclosure: Impact of Psychological Status in Childbearing Options

Genetic Test Results and Disclosure to Family Members: Qualitative Interviews of Healthcare Professionals’ Perceptions of Ethical and Professional Issues in France

Reproductive Endocrinologists’ Utilization of Genetic Counselors for Oncofertility and Preimplantation Genetic Diagnosis (PGD) Treatment of BRCA1/2 Mutation Carriers